Using Existing Drugs in New Ways to Treat & Cure Diseases of Brain & Body | Dr. David Fajgenbaum

Repurposing Success

Repurposing existing drugs has led to transformative outcomes in treating various diseases. David C. Fajgenbaum shares a compelling example of pembrolizumab, initially developed for melanoma and lung cancer, which was later used to treat angiosarcoma, a previously fatal cancer. This discovery extended the lives of patients and changed clinical practices 1. Andrew Huberman and David also discuss how common drugs like aspirin and Viagra have been successfully repurposed for conditions beyond their original uses, such as colon cancer and a rare pediatric lung disease 2.

   

AI & Bioprospecting

Artificial intelligence and bioprospecting are revolutionizing drug discovery by identifying new uses for existing compounds. Andrew Huberman highlights the potential of AI to prioritize drug candidates for further research, expediting the process of finding treatments for diseases like Alzheimer's 3. David C. Fajgenbaum explains how AI can match drugs to diseases, facilitating proactive treatment approaches rather than last-resort measures 4. He emphasizes the importance of leveraging AI to navigate the vast array of existing drugs and natural compounds.

   

Challenges & Incentives

The pharmaceutical industry's focus on patents presents both challenges and opportunities in drug repurposing. Andrew Huberman notes that companies are incentivized to find new applications for existing drugs to extend patents, which can delay the availability of cheaper generics 5. David C. Fajgenbaum adds that while this can hinder innovation, it also allows for the discovery of new therapeutic uses, as seen with aspirin and Viagra 2. This duality underscores the need for a balanced approach to drug development and repurposing.